TABRECTA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0078-0716 -
Package NDC
0078-0716-56 -
Package NDC
0078-0716-94 -
Application number
NDA213591 -
SPL ID
307ab7c9-76d7-47cf-9b7e-38fcbd1b3671 -
SPL set ID
455892c3-d144-4ba8-9ab4-79cabff9876d -
UNII
C2A374O70X -
RxCUI
2362234 -
RxCUI
2362240 -
RxCUI
2362242 -
RxCUI
2362244
What the source publishes
- Labeler
- Novartis Pharmaceuticals Corporation
- Active ingredients
- capmatinib
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TABRECTA",
"splId": "307ab7c9-76d7-47cf-9b7e-38fcbd1b3671",
"labels": [
{
"setId": "455892c3-d144-4ba8-9ab4-79cabff9876d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=455892c3-d144-4ba8-9ab4-79cabff9876d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=455892c3-d144-4ba8-9ab4-79cabff9876d"
}
],
"routes": [
"ORAL"
],
"labeler": "Novartis Pharmaceuticals Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-56)",
"package_ndc": "0078-0716-56",
"identifierStatus": "well-formed",
"marketing_start_date": "20200506"
},
{
"sample": true,
"description": "56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-94)",
"package_ndc": "0078-0716-94",
"identifierStatus": "well-formed",
"marketing_start_date": "20200506"
}
],
"productId": "0078-0716_307ab7c9-76d7-47cf-9b7e-38fcbd1b3671",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "0078-0716",
"deaSchedule": null,
"genericName": "capmatinib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CAPMATINIB HYDROCHLORIDE",
"strength": "200 mg/1"
}
],
"applicationNumber": "NDA213591",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200506",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"C2A374O70X"
],
"rxcui": [
"2362234",
"2362240",
"2362242",
"2362244"
],
"spl_set_id": [
"455892c3-d144-4ba8-9ab4-79cabff9876d"
],
"manufacturer_name": [
"Novartis Pharmaceuticals Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0078-0716_307ab7c9-76d7-47cf-9b7e-38fcbd1b3671"